Amylyx Pharmaceuticals, Inc. (AMLX)
12.21
+0.38
(+3.21%)
USD |
NASDAQ |
Jan 09, 16:00
12.22
+0.01
(+0.08%)
After-Hours: 20:00
Amylyx Pharmaceuticals EPS Diluted (Quarterly): -0.3684 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Treace Medical Concepts, Inc. | -0.2564 |
| Baxter International, Inc. | 0.0175 |
| Humana, Inc. | 1.615 |
| Avantor, Inc. | -1.044 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.39M |
| Total Expenses (Quarterly) | 34.39M |
| Enterprise Value | 1.003B |
| Earnings Yield | -14.74% |
| Normalized Earnings Yield | -14.74 |